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Abstract
As an approach to create a divalent DNA vaccine, a truncated secreted version of bovine herpesvirus-1 (BHV-1) glycoprotein D (tgD)
and the amino-terminal subunit of glycoprotein B (gBb) were expressed from a dicistronic plasmid, designated pSLIAtgD-IRES-gBb.
Intradermal immunization of mice with pSLIAtgD-IRES-gBb or a mixture of plasmids encoding tgD (pSLIAtgD) and gBb (pSLIAgBb) by
needle injection or gene gun elicited strong tgD-specific immune responses. However, a significant reduction in gBb-specific immune
responses was observed upon immunization of mice with pSLIAtgD-IRES-gBb or a mixture of pSLIAtgD and pSLIAgBb in comparison
to immunization with pSLIAgBb alone. This reduction in gBb-specific immune responses induced by pSLIAtgD-IRES-gBb was due to
production of low amounts of gBb from pSLIAtgD-IRES-gBb, inefficient processing and transport of gBb, and possibly competition for
antigen-presenting cells by tgD and gBb. These results indicate that, although divalent plasmids may be used to express different antigens,
the efficacy of vaccination with such plasmids may be influenced by the plasmid design and the characteristics of the expressed antigens.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
DNA vaccines consist of antigen-expressing bacterial plas-
mids capable of inducing humoral and cellular immune re-
sponses. The kinetics, duration, and protective ability of the
immune responses induced by DNA vaccines depend on sev-
eral factors such as the antigen used and species studied (Don-
nelly et al., 1997; van Drunen Littel-van den Hurk et al., 2000).
DNA vaccines have been shown to induce long-lasting pro-
tective immune responses in mice (Donnelly et al., 1997),
which have been the most frequently used species to evaluate
the immunogenicity and efficacy of DNA vaccines in vivo.
Bovine herpes virus-1 (BHV-1) is an economically im-
portant pathogen, which causes severe respiratory and gen-
ital infections in cattle and predisposes the animals to lethal
secondary bacterial infections (Tikoo et al., 1995). Modified
live viral vaccines and subunit vaccines consisting of
BHV-1 surface glycoproteins such as glycoproteins B (gB)
and D (gD) have been promising in protecting cattle against
BHV-1 (van Drunen Littel-van den Hurk et al., 1993; Gao
et al., 1994). However, although these vaccines elicit high
levels of protection, they are expensive and difficult to
manufacture. In comparison, DNA vaccines are relatively
cost-effective and easier to design, manufacture, store, and
transport. They also are safer than live viral vaccines, es-
pecially for infectious agents known to establish latency,
such as herpesviruses. Finally, DNA vaccines generally
induce balanced immune responses and the immune re-
sponses induced by DNA vaccines usually last longer than
the responses elicited by subunit vaccines. Unfortunately,
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the efficacy of DNA vaccines seen in mice has not been
observed in large animals (van Drunen Littel-van den Hurk
et al., 2000). Several strategies have been developed to
enhance DNA vaccine efficacy against BHV-1 in cattle.
These include the use of various promoters, alternate routes
of delivery (van Drunen Littel-van den Hurk et al., 1998),
different antigen forms (Braun et al., 1997; van Drunen
Littel-van den Hurk et al., 1998), and prime-boost regimens
(Loehr et al., 2001). The results obtained with these ap-
proaches indicate that DNA vaccines may offer similar
levels of protection from BHV-1 challenge as killed or
modified live viral vaccines, but in contrast to subunit vac-
cines (van Drunen Littel-van den Hurk et al., 1993; Gao et
al., 1994), they are not completely effective. Therefore,
further improvements are desirable, which emphasizes the
need for the design of novel vaccine vectors.
Multivalent plasmids, expressing several antigens, are
being increasingly used in gene therapy and vaccination
(Wild et al., 1998; Kwissa et al., 2000; Pancholi et al.,
2000). Expression of different proteins may be directed by
two promoters (Kwissa et al., 2000) or a single promoter
with two cistrons (Wild et al., 1998). The aim of this work
was to construct a dicistronic plasmid expressing two gly-
coproteins of BHV-1, a truncated secreted form of gD (tgD)
and the amino-terminal subunit of gB (gBb), and to test the
ability of the plasmid-expressed proteins to induce humoral
and cellular immune responses. Truncated gD was chosen
since plasmid encoding tgD induces stronger immune re-
sponses than plasmid expressing gD (van Drunen Littel-van
den Hurk et al., 1998). BHV-1 gB exists as a covalently
linked heterodimeric complex that can be cleaved into ex-
tracellular amino-terminal gBb (aa 1–505; 74 kDa) and
carboxy-terminal gBc (aa 506–763; 55 kDa), which has a
transmembrane anchor (aa 759–828). The amino-terminal
subunit of gB was chosen, since at least one heparin-binding
domain and several T cell and B cell epitopes have been
identified in this region for mice (Fitzpatrick et al., 1990)
and cattle (Gao et al., 1999). If successful, the immune
responses induced to tgD and gBb should cover a broader
range of protective epitopes and therefore be more effective
than the responses to tgD or gBb alone. However, gBb-
specific immune responses were significantly affected in
mice immunized with the dicistronic plasmid or a mixture
of monocistronic plasmids in a single injection. This reduc-
tion was not apparent when plasmids expressing tgD and
gBb were administered in different sites.
Results
Truncated gD and gBb expressed by pSLIAtgD-IRES-gBb
in transfected Cos-7 cell supernatants are recognized by
gD- and gB-specific monoclonal antibodies
To determine if pSLIAtgD-IRES-gBb expresses tgD and
gBb as individual proteins in eukaryotic cells, Cos-7 cells
were transfected with pSLIAtgD-IRES-gBb (Fig. 1), pSLI-
AtgD, p3KHSPgBb, or pSLIA0. Proteins in the superna-
tants from the transfected cells were precipitated with a
cocktail of gD-specific (Hughes et al., 1988) or gB-specific
(van Drunen Littel-van den Hurk et al., 1984, 1985) mono-
clonal antibodies. Supernatants from untransfected (Fig. 2a,
lanes 1 and 2) or pSLIA0 transfected (Fig. 2a, lanes 3 and
4) cells showed no reaction with gD-specific or gB-specific
antibodies. Proteins with apparent molecular weights of 74
kDa (gBb) and 61 kDa (tgD) were precipitated from super-
natants of pSLIAtgD-IRES-gBb transfected cells (Fig. 2a,
lanes 5 and 6), suggesting that pSLIAtgD-IRES-gBb ex-
presses both gBb and tgD. As expected, tgD and gBb were
precipitated from supernatants of pSLIAtgD (Fig. 2a, lane
8) and p3KHSPgBb (Fig. 2a, lane 9) transfected cells, re-
spectively. To further compare the conformation of tgD and
gBb expressed by the dicistronic plasmid with that of the
monocistronic counterparts, both conformation-dependent
and -independent monoclonal antibodies (Clones 9D6, 136,
3E7, 10C2, 3C1, 2C8, 4C1 and 3D9S) (Hughes et al., 1988)
were used to precipitate proteins produced by pSLIAtgD-
IRES-gBb and pSLIAtgD. Similarly, pSLIAtgD-IRES-gBb
and p3KHSPgBb transfected Cos-7 cell supernatants were
precipitated with seven different gB-specific monoclonal
antibodies (Clones 3F3, 1E11, 1F8, 3C7, 3G11, 5G11,
6G11) (van Drunen Littel-van den Hurk et al., 1984, 1985).
All gD-specific monoclonal antibodies reacted with the 61-
kDa protein in supernatants of both pSLIAtgD and pSLI-
AtgD-IRES-gBb transfected cells (Fig. 2b), while all gB-
specific monoclonal antibodies recognized the 74-kDa
protein in supernatants of both p3KHSPgBb and pSLIAtgD-
IRES-gBb transfected cells (Fig. 2c). However, the reaction
of the gB-specific monoclonal antibodies with gBb ex-
pressed by the dicistronic plasmid appeared to be weaker
than the recognition of gBb produced by the monocistronic
Fig. 1. pSLIAtgD-IRES-gBb. The PvuII-EcoRV fragment containing gBb
downstream of EMCV IRES was inserted behind the coding sequences of
tgD in the expression vector, pSLIA0, containing the HCMV IE promoter
and BGH poly (A) tail.
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plasmid. This may be due to the expression of lower
amounts of gBb in pSLIAtgD-IRES-gBb transfected cells
and/or overall lower reactivity of gBb as observed earlier
with monoclonal antibodies 5G11 and 6G11 (Li et al.,
1996b). There also appeared to be a slightly weaker recog-
nition of gD epitopes by monoclonal antibodies 9D6, 136,
3E7, 3C1, and 2C8 (lanes 1, 3, 5, 9, 11), which may be due
to conformational changes or lower expression of tgD from
the dicistronic plasmid. These results suggest that although
tgD and gBb are expressed from pSLIAtgD-IRES-gBb,
lower amounts might be produced from the dicistronic plas-
mid or the expressed proteins might have some conforma-
tional changes.
Intradermal immunization of mice with pSLIAtgD-IRES-
gBb induces significantly lower gBb-specific immune
responses compared to immunization with pSLIAgBb
Once we demonstrated that each of our constructs was
expressing the desired proteins, we investigated the ability
of pSLIAtgD-IRES-gBb to elicit tgD-specific and gBb-spe-
cific immune responses in mice. The ability of pSLIAtgD to
induce antibody responses in mice has been previously
investigated (Braun et al., 1998). However, although gBb
and gB have been shown to induce similar antibody re-
sponses (Li et al., 1996b), the immunogenicity of plasmid-
expressed gBb has not been tested. Our in vitro studies were
performed with p3KHSPgBb, since gBb produced by this
plasmid has been previously characterized (Li et al., 1996b).
However, for the purpose of immunization, we needed to
control for the effect of promoter strength and plasmid
backbone sequences; therefore, pSLIAgBb was constructed
and tested in Cos-7 cells. The panel of gB-specific mono-
clonal antibodies described above identified a 74-kDa pro-
tein in supernatants of pSLIAgBb transfected cells (data not
shown), confirming the expression of gBb. Subsequently, a
dose titration of pSLIAgBb and pSLIAtgD-IRES-gBb was
performed. C57B1/6 mice were immunized three times by
intradermal injection with 2, 6, or 18 g of either pSLI-
Fig. 2. In vitro expression of tgD and gBb in pSLIAtgD-IRES-gBb transfected cells. (a) Cos-7 cells were left untransfected (lanes 1, 2) or transiently
transfected with pSLIA0 (lanes 3, 4), pSLIAtgD-IRES-gBb (lanes 5, 6), pSLIAtgD (lanes 7, 8), or p3KHSPgBb (lanes 9, 10). Radiolabeled proteins in culture
supernatants were precipitated with a cocktail of gB-specific monoclonal antibodies (lanes 1, 3, 5, 7, 9) or gD-specific monoclonal antibodies (lanes 2, 4, 6,
8, 10). (b) Proteins were precipitated from supernatants of pSLIAtgD-IRES-gBb (lanes 1, 3, 5, 7, 9, 11, 13, 15) or pSLIAtgD (lanes 2, 4, 6, 8, 10, 12, 14,
16) transfected Cos-7 cells by gD-specific monoclonal antibody 9D6 (lanes 1, 2), 136 (lanes 3, 4), 3E7 (lanes 5, 6), 10C2 (lanes 7, 8), 3C1 (lanes 9, 10),
2C8 (lanes 11, 12), 4C1 (lanes 13, 14), or 3D9S (lanes 15, 16). (c) Proteins were precipitated from supernatants of pSLIAtgD-IRES-gBb (lanes 1, 3, 5, 7,
9, 11, 13) or p3KHSPgBb (lanes 2, 4, 6, 8, 10, 12) transfected Cos-7 cells by gB-specific monoclonal antibody 3F3 (lanes 1, 2), 1E11 (lanes 3, 4), 1F8 (lanes
5, 6), 3C7 (lanes 7, 8), 3G11 (lanes 9, 10), 5G11 (lanes 11, 12), or 6G11 (lanes 13, 14). All proteins were separated by SDS–PAGE on an 8.5% gel under
reducing conditions.
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AgBb or pSLIAtgD-IRES-gBb. Since we anticipated that
the small difference in size between the monocistronic
(7139 kb) and dicistronic gBb-expressing plasmids (8858
kb) would not influence the transfection efficiency in vivo to
a greater extent than the natural variation in transfection
levels after intradermal injection, microgram amounts were
chosen for this experiment. After the third immunization,
there were significantly higher gBb-specific antibody titers
(Fig. 3a) and levels of IFN- secretion (Fig. 3c) in mice
immunized with pSLIAgBb than in mice injected with sa-
line (P  0.01), regardless of the dose of plasmid used for
immunization. However, the gBb-specific antibody and cel-
lular immune responses in mice immunized with any dose
of pSLIAtgD-IRES-gBb were not different from the re-
sponses of the saline injected mice, and significantly lower
than the responses of the pSLIAgBb immunized mice (P 
0.05) (Figs. 3a and c). In contrast, pSLIAtgD-IRES-gBb
immunized mice showed significantly higher tgD-specific
antibody titers (P  0.01; Fig. 3b) and levels of IFN-
secretion (P  0.01; Fig. 3d) when compared to mice
injected with saline. There were no detectable levels of IL-5
in any of the groups (data not shown). These results were
confirmed in a second experiment. The reduction of the
gBb-specific immune responses in pSLIAtgD-IRES-gBb
immunized mice may be due to factors such as inefficient
translation of gBb from the IRES (Mizuguchi et al., 2000),
inefficient processing and transport of gBb, or antigenic
competition between tgD and gBb.
Exhaustive immunoprecipitation with a gB-specific
monoclonal antibody cocktail demonstrates reduced
production of gBb by pSLIAtgD-IRES-gBb
In our previous experiments, there appeared to be re-
duced expression of gBb in pSLIAtgD-IRES-gBb trans-
fected cell supernatants, as well as lower gBb-specific im-
mune responses in mice immunized with pSLIAtgD-IRES-
gBb. To confirm that the amount of gBb expressed by the
dicistronic plasmid was indeed lower, gBb produced in
supernatants of cells transfected with pSLIAtgD-IRES-gBb
or pSLIAgBb was exhaustively precipitated at 24 h post-
transfection. In contrast to supernatants from pSLIAgBb
transfected cells, supernatants from pSLIAtgD-IRES-gBb
transfected cells did not contain detectable levels of gBb
after the third immunoprecipitation (Fig. 4, lanes 5 and 6).
These results show that indeed the amount of gBb expressed
by the dicistronic plasmid is lower than that expressed by
pSLIAgBb, which may have contributed to the lower gBb-
specific immune responses induced by immunization with
pSLIAtgD-IRES-gBb (Fig. 3a).
Fig. 3. Immune responses induced by intradermal injection with pSLIAgBb or pSLIAtgD-IRES-gBb. C57BL/6 mice were injected intradermally with 2, 6,
or 18 g of pSLIAgBb (n  5) or pSLIAtgD-IRES-gBb (n  5). All responses were measured 1 week posttertiary immunization. (a) gBb-specific and (b)
tgD-specific geometric mean serum ELISA titers  SEM of pSLIAgBb and pSLIAtgD-IRES-gBb immunized mice; (c) gBb-specific and (d) tgD-specific
geometric mean IFN- secretion  SEM of pSLIAgBb and pSLIAtgD-IRES-gBb immunized mice. ELISA titers were calculated as the reciprocal serum
dilution at which the OD reading was 2 standard deviation of a standard negative serum. ** Significance of differences from the saline injected group (P
 0.01). , Significance of differences between pSLIAgBb and pSLIAtgD-IRES-gBb immunized groups (P  0.05).
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Pulse-chase analysis of pSLIAtgD-IRES-gBb shows
marked reduction in the synthesis of both precursor and
mature forms of gBb
Since it was evident that lower amounts of gBb were
produced in pSLIAtgD-IRES-gBb transfected cells, we sub-
sequently investigated whether this was due to reduced
protein synthesis or inefficient processing and transport. To
analyze the production and processing of tgD and gBb, a
pulse-chase experiment was performed. Cos-7 cells were
transfected with pSLIAgBb (Figs. 5a and b, lanes 1–6),
pSLIAtgD (Figs. 5c and d, lanes 1–6), or pSLIAtgD-IRES-
gBb (Fig. 5, lanes 7–12), and cell lysates and supernatants
of the transfected cells were analyzed at various time points
using gB- and gD-specific monoclonal antibody cocktails.
The overall processing of gBb and tgD was similar in
pSLIAtgD-IRES-gBb transfected cells compared to pSLI-
AgBb and pSLIAtgD transfected cells. However, there were
differences in the amounts of the precursor and mature
forms of gBb synthesized in cells transfected with the
monocistronic and dicistronic plasmids. As shown in Fig.
5a, high amounts of gBb precursor were present at time 0 in
pSLIAgBb transfected cells (lanes 1–6) in contrast to pSLI-
AtgD-IRES-gBb transfected cells (lanes 7–12), where in-
creased amounts of gBb precursor were not detected until
120 min after the pulse. Fully processed gBb was first
detected at about 60 min in both pSLIAgBb (Fig. 5b, lanes
1–6) and pSLIAtgD-IRES-gBb (Fig 5b, lanes 7–12) trans-
fected cell-culture supernatants, but the amounts produced
by pSLIAtgD-IRES-gBb were very low. In the cell lysates
of both pSLIAtgD (Fig. 5c, lanes 1–6) and pSLIAtgD-
IRES-gBb (Fig. 5c, lanes 7–12) transfected cells there was
a steady conversion of tgD precursor to the mature protein
from 15 min of labeling. Mature tgD was detected from 30
min onward in both pSLIAtgD and pSLIAtgD-IRES-gBb
transfected cell supernatants (Fig. 5d). These results suggest
that the lower amount of gBb detected in supernatants from
pSLIAtgD-IRES-gBb transfected cells is due to reduced
synthesis of gBb precursor, as well as less efficient process-
ing, transport, and secretion of gBb. Interestingly, there
appeared to be an accumulation of mature tgD in cells
transfected with pSLIAtgD or pSLIAtgD-IRES-gBb,
whereas all of the mature gBb present in cells transfected
with pSLIAtgD-IRES-gBb or pSLIAgBb was secreted.
Therefore, it may be possible that the presence of large
amounts of mature tgD interferes with the synthesis and
processing of gBb, leading to lower amounts of mature gBb
in the supernatants of transfected cells.
Glycoprotein Bb-specific antibody responses are
significantly reduced in mice immunized intradermally
with pSLIAtgD-IRES-gBb or a mixture of pSLIAtgD and
pSLIAgBb
It is very likely that the low amount of fully processed
gBb expressed by pSLIAtgD-IRES-gBb contributed to the
reduced gBb-specific immune responses induced by the
dicistronic plasmid. However, other factors may also be
involved, such as coexpression of antigen in the same cell or
site. To test this possibility, mice were immunized with
pSLIAgBb, pSLIAtgD, pSLIAtgD-IRES-gBb, or a mixture
of pSLIAtgD and pSLIAgBb. The 6 g dose was chosen for
this experiment, since immunization with 2 g of pSLI-
AgBb showed a greater variation among mice in gBb-
specific antibody responses, whereas the 18 g dose could
mask any effects due to mixing of plasmids. To equalize
Fig. 5. Processing of tgD and gBb in pSLIAtgD-IRES-gBb, pSLIAgBb,
and pSLIAtgD transfected cells. Cos-7 cells transiently transfected with
pSLIAgBb, pSLIAtgD, or pSLIAtgD-IRES-gBb were labeled with 35S-
labeled Met/Cys for 15 min and then incubated in medium containing
excess unlabeled Met/Cys for 15, 30, 60, 90, or 120 min (as indicated
above the gels). (a) Cell lysates and (b) supernatants of pSLIAgBb (lanes
1–6) and pSLIAtgD-IRES-gBb (lanes 7–12) transfected cells were immu-
noprecipitated with gB-specific monoclonal antibody cocktail. (c) Cell
lysates and (d) supernatants of pSLIAtgD (lanes 1–6) and pSLIAtgD-
IRES-gBb (lanes 7–12) transfected cells were immunoprecipitated with
gD-specific monoclonal antibody cocktail. Lane numbers are indicated
below the gels. Precursors of gBb and tgD are indicated as pgBb and ptgD,
respectively. Proteins were separated by SDS–PAGE on an 8.5% gel under
reducing conditions.
Fig. 4. Exhaustive immunoprecipitation of gBb from supernatants of pSLI-
AgBb and pSLIAtgD-IRES-gBb transfected cells. Radiolabeled proteins in
culture supernatants of pSLIAgBb (lanes 1, 3, 5) and pSLIAtgD-IRES-gBb
(lanes 2, 4, 6) transfected Cos-7 cells were precipitated three times (1, 2,
and 3) with gB-specific monoclonal antibody cocktail. Proteins were sep-
arated by SDS–PAGE on an 8.5% gel under reducing conditions.
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plasmid backbone in all groups, pSLIA0 was added to
groups that received only one plasmid. Mice vaccinated
with pSLIAgBb, or pSLIAgBb and pSLIAtgD in separate
sites, developed significantly higher gBb-specific antibody
titers than the pSLIA0 immunized mice (P  0.01 and P 
0.05, respectively; Fig. 6a). In contrast, there was no dif-
ference between the gBb-specific antibody responses in-
duced by pSLIAtgD-IRES-gBb, or a mixture of pSLIAgBb
and pSLIAtgD, and the responses elicited by pSLIA0. In
addition, there was a significant difference (P  0.05)
between the gBb-specific antibody responses induced by
pSLIAgBb and the responses elicited by pSLIAtgD-IRES-
tgBb or the mixture of plasmids encoding gBb and tgD. All
mice vaccinated with plasmid(s) expressing gBb and/or
tgD, including pSLIAtgD-IRES-gBb, showed significantly
higher gBb-specific IFN- secretion than mice vaccinated
with pSLIA0 (P  0.05) (Fig. 6c). Interestingly, this is in
contrast to the previous experiment, where there was no
significant difference in gBb-specific cellular responses be-
tween the pSLIAtgD-IRES-gBb and pSLIA0 immunized
mice. This might be due to the presence of additional im-
munostimulatory sequences present in the plasmid back-
bone added in the formulation, which may have aided in
enhancing cellular responses (Donnelly et al., 1997). There
was no significant difference in tgD-specific antibody (Fig.
6b) and cellular immune (Fig. 6d) responses among any of
the groups vaccinated with plasmid(s) encoding tgD and/or
gBb. All of these groups developed significantly higher
immune responses than the group injected with pSLIA0 (P
 0.01). These results suggest that, since there was a re-
duced gBb-specific antibody response when plasmids en-
coding tgD and gBb were delivered together, the reduction
in gBb-specific responses might also be due to antigenic
interference or competition for plasmid uptake.
Fig. 6. Immune responses induced by intradermal injection with monocistronic or discistronic plasmids expressing tgD and gBb. C57BL/6 mice were injected
intradermally with pSLIA0, pSLIAgBb, pSLIAtgD, pSLIAtgD  pSLIAgBb (one injection), pSLIAtgD  pSLIAgBb (two injections, two sites), or
pSLIAtgD-IRES-gBb (n  7 for all groups). Groups immunized with single plasmid also received one shot of pSLIA0 to equalize plasmid backbone in all
groups. All responses were measured 2 weeks postsecondary immunization. (a) gBb- and (b) tgD-specific geometric mean serum ELISA titers  SEM; (c)
gBb- and (d) tgD-specific geometric mean IFN- secretion  SEM. ELISA titers were calculated as the reciprocal serum dilution at which the OD reading
was 2 standard deviation of a standard negative control serum. Asterisks indicate significance of differences from the pSLIA0 injected group (**P  0.01;
*P  0.05). , Significance of differences between the pSLIAgBb vaccinated group and the pSLIAgBb  pSLIAtgD or pSLIAtgD-IRES-gBb immunized
groups (P  0.05).
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Coimmunization of mice with pSLIAtgD and pSLIAgBb by
gene gun results in decreased gBb-specific antibody
responses
A consistent reduction of gBb-specific immune re-
sponses observed in mice immunized with pSLIAtgD-
IRES-gBb or a mixture of pSLIAtgD and pSLIAgBb indi-
cated a potential inhibitory effect when both proteins are
expressed in the same cell or the same microenvironment.
Plasmid uptake by intradermal immunization is a matter of
statistical variation and this may lead to unbalanced expres-
sion of proteins, which may contribute toward lower gBb-
specific antibody responses. To confirm that the reduction
of gBb-specific immune responses was not due to differ-
ences in plasmid uptake, we used the gene gun to ensure
delivery of both plasmids in equivalent amounts in the same
cell, thereby “mimicking” the immunization with pSLI-
AtgD-IRES-gBb. Mice were immunized twice with gold
beads coated with equal molar ratios of pSLIAgBb, pSLI-
AtgD, pSLIAtgD-IRES-gBb, or various combinations of
pSLIAtgD and pSLIAgBb. Fig. 7 demonstrates that mice
vaccinated with gBb encoding plasmid had significantly
higher gBb-specific antibody titers than mice injected with
pSLIA0 (P  0.001). Mice immunized with pSLIAtgD and
pSLIAgBb in separate sites, or with gold beads separately
coated with pSLIAtgD or pSLIAgBb, developed compara-
ble gBb-specific antibody titers to pSLIAgBb immunized
mice. However, mice immunized with pSLIAtgD-IRES-
gBb or gold beads coated with premixed pSLIAtgD and
pSLIAgBb displayed significantly lower gBb-specific anti-
body titers than mice immunized with pSLIAgBb (P 
0.05). This may be due to a higher probability of delivering
both plasmids into the same cell when gold beads are coated
with premixed pSLIAtgD and pSLIAgBb than when gold
beads are coated with either plasmid. These results further
confirm that a reduction in gBb-specific antibody responses
occurs when both tgD and gBb are produced in the same
cell. All groups vaccinated with plasmid(s) encoding tgD
and/or gBb had significantly higher tgD-specific antibody
responses than the pSLIA0 immunized group (Fig. 7b). No
significant levels of gBb- or tgD-specific IFN- or IL-5
secretion by splenocytes were detected in any of these
groups (data not shown). Similar results were obtained
when bullets were coated with a four-fold higher amount of
plasmid (data not shown). These results confirm that irre-
spective of delivery route, a reduction in gBb-specific anti-
body responses occurs when tgD and gBb are expressed
together in the same cell. The reduction in gBb-specific
antibody responses was not as pronounced as the decrease
observed after intradermal immunization. This is likely due
to the fact that gene gun mediated delivery is more efficient,
resulting in higher transfection efficiency. With larger num-
bers of plasmid producing gBb from the IRES, the relatively
low amount produced per plasmid might not be as limiting
to the development of an immune response as after intra-
dermal delivery.
Discussion
Multivalent DNA vaccines are advantageous in that mul-
tiple antigens from the same or different pathogens can be
expressed simultaneously. The simplest way to deliver mul-
tiple genes is administration of a mixture of monocistronic
plasmids coding for the antigens of interest. However, with
discovery of elements such as an internal ribosome entry
site (IRES) in many viruses (Ghattas et al., 1991; Wang et
al., 1993), polycistronic plasmids, which can express mul-
Fig. 7. Immune responses induced by gene gun mediated delivery of
monocistronic or dicistronic plasmids expressing tgD and gBb. C57BL/6
mice were immunized intradermally by gene gun with (1) 6.5  1010
pSLIA0; (2) 6.5  1010 pSLIAgBb; (3) 6.5  1010 pSLIAtgD; (4) a
combination of 3.3  1010 each of pSLIAtgD and pSLIAgBb (plasmids
were individually coated on gold beads, mixed, and delivered as one shot;
mix); (5) 3.3  1010 each of pSLIAtgD and pSLIAgBb (plasmids were
mixed, coated on gold beads, and delivered as one shot; premix); (6) 6.5 
1010 pSLIAtgD  6.5  1010 pSLIAgBb (delivered as two shots); or (7)
6.5 1010 pSLIAtgD-IRES-gBb (n 7). An additional shot of 6.5 1010
pSLIA0 was administered to all but group 6 to equalize plasmid backbone.
All responses were measured 2 weeks postsecondary immunization. (a)
gBb- and (b) tgD-specific geometric mean serum ELISA titers  SEM.
ELISA titers were calculated as the reciprocal serum dilution at which the
OD reading was 2 standard deviation of a standard negative control
serum. Asterisks indicate significance of differences from the pSLIA0
vaccinated group (***P  0.001; **p  0.01). , Significance of differ-
ences between the pSLIAgBb vaccinated group and the pSLIAgBb/pSLI-
AtgD premix or pSLIAtgD-IRES-gBb immunized groups (P  0.05).
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tiple proteins from a single mRNA, have been constructed.
This approach may reduce the amount of DNA used for
immunization by coexpressing different antigens from var-
ious cistrons (Kirchhoff et al., 1995). Polycistronic retrovi-
ral vectors have been used (Staal et al., 1996) in gene
therapy to express cytokines such as IL-7 (Sharma et al.,
1996), and granulocyte monocyte-colony stimulating factor
(GM-CSF) (Guan et al., 2001) simultaneously with the gene
of interest as an approach to enhance immune responses.
A dicistronic plasmid, pSLIAtgD-IRES-gBb, was con-
structed and tested in mice. The expression of tgD and gBb
from this plasmid in Cos-7 cells was confirmed by detection
with gD- and gB-specific monoclonal antibody cocktails
and reactivity with individual monoclonal antibodies, indi-
cating that both tgD and gBb retained the authentic confor-
mation. Although there seemed to be weaker recognition by
certain gD-specific monoclonal antibodies, the tgD-specific
immune responses in mice immunized with pSLIAtgD-
IRES-gBb were not affected. However, the overall reduced
reactivity of gB-specific monoclonal antibodies with gBb
expressed by the dicistronic plasmid, together with the re-
duced gBb-specific immune responses in mice immunized
with pSLIAtgD-IRES-gBb, suggested a potential problem
with the production, processing, or secretion of gBb.
Antigens encoded by a single plasmid (Wild et al., 1998;
Kwissa et al., 2000) or multiple plasmids have been re-
ported to successfully induce immune responses to all com-
ponents (Grifantini et al., 1998; Musacchio et al., 2001).
However, in the present study immunization of mice with
dicistronic plasmid expressing tgD and gBb resulted in
significant reduction in gBb-specific immune responses. Al-
though both gBb-specific humoral and cellular immune re-
sponses were significantly lower in pSLIAtgD-IRES-gBb
immunized mice, the difference in antibody responses was
more pronounced. Similarly, a reduction in the gBb-specific
antibody response was observed when a mixture of mono-
cistronic plasmids encoding tgD and gBb was administered
by single intradermal injection. Since effective cellular re-
sponses can be induced with low doses of antigen (O’Hagan
et al., 2001), an immediate explanation for the reduced
gBb-specific immune responses elicited by pSLIAtgD-
IRES-gBb is the inefficient expression of gBb. Several
arguments support this possibility. Exhaustive immunopre-
cipitation of supernatants from pSLIAtgD-IRES-gBb trans-
fected cells with gBb-specific monoclonal antibodies dem-
onstrated a dramatic reduction in the amount of gBb by the
third time. This was confirmed by pulse-chase analysis,
which showed the production of lower amounts of precursor
and mature forms of gBb in cells transfected with pSLI-
AtgD-IRES-gBb compared to pSLIAgBb transfected cells.
These results may be due to the varying translational effi-
ciency of the IRES element (Mizuguchi et al., 2000), since
the expression of gBb by the monocistronic plasmid was
higher. To determine if insertion of gBb upstream of IRES
enhanced expression of gBb, the positions of the tgD and
gBb coding sequences were reversed and pSLIAgBb-IRES-
tgD was constructed. Although the expression of gBb by
pSLIAgBb and pSLIAgBb-IRES-tgD was comparable, no
expression of tgD by pSLIAgBb-IRES-tgD was detected
(data not shown).
Another possible explanation for the reduction of gBb
expression in pSLIAtgD-IRES-gBb transfected cells may be
the large accumulation of mature tgD in these cells. Al-
though the production of high amounts of tgD may be due
to the efficiency of transcription from the HCMV promoter,
similar accumulation of gBb from the same promoter was
not observed. Therefore, the accumulation of mature tgD in
the cells may be related to the characteristic of gD that
mediates resistance to further BHV-1 infection, promoting
virus spread to tissues and enhancing virus infection (Chase
et al., 1993; Campadelli-Fiume et al., 2000). The presence
of large amounts of tgD in cells transfected in vitro or in
vivo may also be expected to interfere with the processing
and presentation of other proteins expressed in the same cell
by saturating the glycosylation and transport machineries
responsible for exporting proteins from the endoplasmic
reticulum to the Golgi apparatus.
Alternatively, the characteristics of the signal peptides
may play a role in determining the preference of the glyco-
proteins that enter the secretory pathway. The hydrophobic-
ity of signal peptides has been shown to correlate with the
ability of precursors to accomplish different stages of the
secretion process (Kumamoto and Beckwith, 1985; Kum-
amoto, 1991). From hydophobicity analyses using the
Kyte–Doolittle method (Kyte and Doolittle, 1982) with a
window size of 7 aa, the signal sequence of gD (17 aa)
appeared to be more hydrophobic compared to that of gB
(49 aa) (Ros and Belak, 2002), possibly providing tgD with
an advantage over gBb. In support of this hypothesis, Rusch
et al. (1994) have shown that mutant proteins with highly
hydrophobic signal peptides interfere with the secretion of
wild-type proteins, suggesting a possible competition with
other preproteins for one or more components of the secre-
tory pathway. Chen et al. (1996) further showed that when
two functional signal peptides are arranged in tandem, there
is a strong preference to utilize the most hydrophobic one.
Although these studies have been demonstrated in bacteria,
the structure of signal sequences and the functioning of the
secretory machinery are generally well conserved from pro-
karyotes to eukaryotes (Galliciotti et al., 2001). Therefore,
this may also explain the presence of lower amounts of gBb
in the supernatants of pSLIAtgD-IRES-gBb. An important
implication of these speculations is that, when tgD and gBb
are produced together in the same cell, the factors that favor
the rapid expression and secretion of tgD may also lead to
rapid processing followed by binding of tgD peptides to
major histocompatibility complex (MHC) molecules for
faster presentation and induction of an immune response.
The phenomenon of antigenic competition, in which im-
mune responses to one determinant are inhibited by simul-
taneous exposure to antigens on the same or different mol-
ecules, has been known for a long time (Liacopoulos and
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Ben-Efraim, 1975). Antigenic competition may occur at the
level of antigen presentation. It has been suggested that
competition between T cells only occurs if they are respond-
ing to different peptides presented on the same antigen-
presenting cell (APC) (Kedl et al., 2000). In our experi-
ments, immunization of mice with pSLIAtgD-IRES-gBb, or
a mixture of pSLIAtgD and pSLIAgBb in a single formu-
lation as an injection or on gold beads, might result in
presentation of both tgD and gBb peptides by the same
APC, causing competition between T cells. Alternatively,
since animals immunized with a mixture of pSLIAtgD and
pSLIAgBb or with pSLIAtgD-IRES-gBb displayed signifi-
cant tgD-specific T cell responses, tgD-specific T cells
could have provided help to gBb-specific B cells. However,
this was not observed, so there might have been competition
between tgD- and gBb-specific B cells for the T cell help,
which may be another reason for the reduced gBb-specific B
cell response in animals immunized with the dicistronic
plasmid. In addition, APCs play a crucial role in narrowing
the choice of determinants on the protein to which a re-
sponse will be mounted and the nature of that response
(Schneider and Sercarz, 1997). Therefore, it may also be
possible that tgD possesses more immunodominant epitopes
than gBb, which could initiate stronger tgD-specific im-
mune responses that may be specific for the species studied.
In support of this contention, O’Hagan et al. (2001) ob-
served hyporesponsiveness to HIV env protein upon immu-
nization with a combination of naked DNA encoding HIV
gag and env only in the guinea pig model, and not in mice
or rabbits.
In general, antibody responses have been dependent on
plasmid dose used for immunization (Donnelly et al., 1997),
but in some studies, this dependence seems to be lost with
time as the antibody titers become equivalent irrespective of
the dose (Rhodes et al., 1994) or number of injections (Deck
et al., 1997). In our studies, gBb-specific antibody titers
could not be enhanced in pSLIAtgD-IRES-gBb immunized
animals even with doses as high as 18 g by intradermal
injection or 2 g by gene gun. This may be explained by the
fact that at the higher doses of pSLIAtgD-IRES-gBb more
tgD is produced, which may result in increased competition
of tgD with gBb.
Collectively, the reduction in gBb-specific immune re-
sponses in mice immunized with pSLIAtgD-IRES-gBb may
be ascribed to a combination of factors, including low-
translational efficiency of gBb from IRES, competition by
tgD with processing, secretion and transport of gBb, and
interference with the induction of gBb-specific immune
responses. Plasmid-expressed gD has also been shown to
have inhibitory effects in other plasmid formulations (Braun
et al., 1998). However, gD still remains one of the most
crucial antigens for induction of protection, so it should not
be excluded from vaccines against BHV-1. Therefore, to
avoid reduction in immune responses to any component of
a divalent or a multivalent DNA vaccine encoding BHV-1
gD and other immunogens, it may be advantageous to im-
munize in multiple sites, as this may provide separate mi-
croenvironments for each antigen to induce an immune
response. Alternatively, the construction of DNA vaccines
encoding chimeric fusion proteins may offer a promising
strategy to overcome these difficulties.
In summary, the construction of dicistronic plasmids
may represent a promising approach to coexpress several
gene products that may enhance the efficacy of DNA vac-
cines (Wild et al., 1998; Pancholi et al., 2000). Wild et al.
(1998) have shown successful induction of immune re-
sponses to core and surface antigens of hepatitis virus en-
coded from a dicistronic plasmid. However, the results from
our study suggest that the ability of each of two antigens to
induce the desired immune responses in the same microen-
vironment depends on their individual physical properties,
which may influence the intracellular synthesis and process-
ing, and consequently the induction of immunity.
Materials and methods
All restriction enzymes, DNA-modifying enzymes, mo-
lecular weight markers, and plasmids were purchased from
Pharmacia Biotech (Baie d’Urfe´, QC) and New England
Biolabs Ltd. (Mississauga, ON). All cell-culture incubations
were performed at 37°C in 5% CO2, unless otherwise spec-
ified.
Construction of plasmids
pSLIAtgD (6542 kb) was created by inserting the coding
sequence for tgD of BHV-1 into the pSLIA0 vector (Braun
et al., 1998). To construct pSLIAtgD-IRES-gBb (Fig. 1;
8858 kb), the pCITE vector bearing the sequence of equine
cytomegalovirus (ECMV) IRES (Invitrogen, Burlington,
ON) was used. pIRES-gBb plasmid was first constructed by
inserting the NcoI-EcoRV fragment from p3KHSPgBb
(8864 kb) (Li et al., 1996a) bearing the coding sequence of
gBb, including the signal sequence, into the NcoI-EcoRV
site on the pCITE vector to create pCITE-gBb. The PvuII-
EcoRV fragment containing IRES-gBb was inserted into the
EcoRV site on pSLIAtgD. pSLIAgBb (7139 kb) was con-
structed by ligation of a Klenow-digested NcoI-HincII frag-
ment of pIRES-gBb, bearing the coding sequence of gBb,
into the Klenow-digested XbaI site of pSLIA0.
Plasmids were grown in Escherichia coli DH5 and
purified by anion exchange resin (Qiagen, Mississagua, ON)
followed by Triton X-114 (Sigma-Aldrich, Oakville, ON)
extraction (Cotten et al., 1994) to reduce endotoxin levels to
10 EU (10 pg/ml of DNA). The concentration was
assessed spectrophotometrically, and constructs were con-
firmed by restriction enzyme digestion followed by agarose
gel electrophoresis.
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Transfection
Cos-7 cells were seeded at a concentration of 2.5  105
cells/well in six-well plates (Corning, Corning, NY) in
DMEM (Canadian Life Technologies, Burlington, ON) with
10% fetal bovine serum (FBS) (Sigma-Aldrich) and cul-
tured overnight. They were then transfected with pSLI-
AtgD, pSLIAtgD-IRES-gBb, p3KHSPgBb, or pSLIAgBb
using Lipofectamine Plus Reagent (Canadian Life Technol-
ogies) according to the manufacturer’s instructions. After
5 h incubation with transfection mixture, DMEM containing
10% FBS was added to the transfected Cos-7 cells.
Radioimmunoprecipitation
At 24 h posttransfection, the culture medium was re-
moved from the transfected Cos-7 cells. Fresh methionine
and cysteine (Met/Cys)-free MEM (Sigma-Aldrich) was
added to the transfected cells and the cells were incubated
for 2 h. Subsequently, 50 Ci of 35S-labeled Met/Cys (Man-
del Scientific Co., Guelph, ON) was added and the cells
were incubated overnight. The culture supernatants were
collected and incubated with a 1:100 dilution of mouse
ascites containing gB-specific monoclonal antibodies
(Clones 3F3, 1E11, 1F8, 3C7, 3G11, 5G11, 6G11) (van
Drunen Littel-van den Hurk et al., 1984, 1985) or gD-
specific monoclonal antibodies (Clones 9D6, 136, 3E7,
10C2, 3C1, 2C8, 4C1, 3D9S) (Hughes et al., 1988) on ice
for 4 h. Protein A-Sepharose beads (Amersham Pharmacia)
were coated with rabbit anti-mouse IgG (Cappel, Aurora,
OH) and subsequently incubated overnight at 4°C with the
protein-bound gB- or gD-specific monoclonal antibodies.
For exhaustive immunoprecipitations, the beads were centri-
fuged and supernatants were immunoprecipitated two more
times. The beads were then washed and resuspended in elec-
trophoresis sample buffer for analysis by sodium dodecyl sul-
phate–polyacrylamide gel electrophoresis (SDS–PAGE) on an
8.5% gel under reducing conditions.
Pulse-chase analysis
Transfection of cells with pSLIAtgD-IRES-gBb, pSLI-
AtgD, and pSLIAgBb was performed as described earlier.
At 24 h posttransfection, cells were starved for Met/Cys in
Met/Cys-free MEM (Sigma-Aldrich) for 1 h. Subsequently,
cells were pulse-labeled for 15 min by addition of 200 Ci
of 35S-labeled Met/Cys (Mandel Scientific Co.). Superna-
tants were removed, and cells were washed in PBS (0.137
M NaCl, 0.003 M KCl, 0.008 M Na2HPO4, 0.001 M
Na2H2PO4, pH 7.4) and further incubated in MEM contain-
ing 1 mM methionine. At different time points, the cells and
supernatants were collected, and samples were precipitated
with gB- and gD-specific monoclonal antibody cocktails
and separated by SDS–PAGE on an 8.5% gel under reduc-
ing conditions.
Immunization of mice
Four- to six-week-old C57B1/6 mice (Charles River,
Kingston, ON) were randomly assigned to experimental
groups and immunized either by intradermal injection on
the back or by gene gun (Helios, Bio-Rad, ON) on the back
and abdomen. At the end of each experiment, mice were
euthanized by halothane overdose. All experiments were
conducted in accordance with the guidelines provided by
the Canadian Council on Animal Care.
To compare immune responses induced by various doses
of pSLIAtgD-IRES-gBb, seven groups of five mice were
immunized with one of the following: I: saline; II: 2 g
pSLIAgBb; III: 2 g pSLIAtgD-IRES-gBb; IV: 6 g pSLI-
AgBb; V: 6 g pSLIAtgD-IRES-gBb; VI: 18 g pSLI-
AgBb; or VII: 18 g pSLIAtgD-IRES-gBb. Secondary and
tertiary immunizations were performed in the same manner
at weeks 6 and 13, respectively. At week 14, sera were
collected to analyze gBb-specific antibody responses, and
splenocytes were isolated to measure gBb-specific cellular
responses.
To compare immune responses induced by monocis-
tronic (pSLIAtgD and pSLIAgBb) and dicistronic (pSLI-
AtgD-IRES-gBb) plasmids expressing tgD and gBb, six
groups of seven mice were immunized with one of the
following: I: 12 g pSLIA0; II: 6 g pSLIAgBb  6 g
pSLIA0; III: 6 g pSLIAtgD  6 g pSLIA0; IV: 6 g
pSLIAtgD  6 g pSLIAgBb (one injection, one site); V:
6 g pSLIAtgD  6 g pSLIAgBb (two injections, two
sites); or VI: 6 g pSLIAtgD-IRES-gBb  6 g pSLIA0.
Secondary immunizations were performed in the same man-
ner at week 4. At week 6, sera were collected to analyze
gBb- and tgD-specific antibody responses, and splenocytes
were isolated to measure antigen-specific cellular responses.
To eliminate the possibility that the reduction in gBb-
specific antibody responses was due to differences in plas-
mid uptake, mice were immunized by gene gun. Six groups
of seven mice were immunized with gold beads coated with
one of the following: I: pSLIA0; II: pSLIAgBb or pSLI-
AtgD; III: pSLIAtgD and pSLIAgBb coated on different
gold beads and delivered in a single shot; IV: pSLIAtgD and
pSLIAgBb mixed prior to coating on the gold beads and
delivered in a single shot; V: pSLIAtgD and pSLIAgBb
delivered as two separate shots; or VI: pSLIAtgD-IRES-
gBb. The conditions for plasmid delivery by gene gun were
a helium pressure of 250 lb/in.2, 0.25 mg of gold, and 6.5
1010 plasmids (ranging from 0.45 to 0.6 g DNA) per shot.
To equalize the plasmid backbone among groups, groups I,
II, and VI were immunized with an extra shot containing 6.5
 1010 pSLIA0. Secondary immunizations were performed
in the same manner at week 4. At week 6, sera were
collected to analyze gBb- and tgD-specific antibody re-
sponses, and splenocytes were isolated to measure antigen-
specific cellular responses.
305S. Manoj et al. / Virology 313 (2003) 296–307
Enzyme-linked immunosorbent assay (ELISA)
Polystyrene microtiter plates (Immulon II, Dynatech
Laboratories, Inc., Alexandria, VA) were coated with 0.05
g/well of tgD (van Drunen Littel-van den Hurk et al.,
1993) or tgB (Li et al., 1996b) overnight at 4°C. Plates were
washed four times in PBS with 0.05% Tween 20 (PBST)
prior to addition of fourfold dilutions of mouse sera pre-
pared in PBST. After 2 h incubation at room temperature
(RT), plates were washed in PBST, and affinity-purified
alkaline phosphatase (AP) conjugated goat anti-mouse IgG
(Kirkegaard & Perry Laboratories) was added at a dilution
of 1:5000 in PBST. After another hour at RT, plates were
washed and reactions were visualized with 0.01 M p-nitro-
phenyl phosphate (PNPP) (Sigma-Aldrich). Absorbance
was read on a model 3550 Microplate Reader (Bio-Rad
Laboratories Ltd., Randolph, MA) at 405 nm, with a refer-
ence wavelength of 490 nm. The titers were calculated as
the reciprocal serum dilution at which the OD reading was
2 standard deviation of a negative control serum.
Isolation of splenocytes
Isolation of splenocytes from mice has been described in
detail (Lewis et al., 1999). Briefly, splenocytes were iso-
lated by gentle homogenization of the spleens. Most red
cells were removed by lysis for 1 min with ammonium
chloride buffer (0.14 M NH4Cl, 0.017 M Tris–HCl, pH 7.2).
After two washes, the splenocytes were resuspended at a
final concentration of 1  107 cells/ml in RPMI 1640
supplemented with 10% FBS (Sigma-Aldrich), 100 U/ml
penicillin, 100 g/ml streptomycin (Sigma-Aldrich), 2 mM
L-glutamine (Canadian Life Technologies), 100 M nones-
sential amino acids (Canadian Life Technologies), 1 mM
sodium pyruvate (Canadian Life Technologies), 10 mM
HEPES (Canadian Life Technologies), and 5  105 M
2--mercaptoethanol (Sigma-Aldrich).
Cytokine ELISA
Splenocytes at a concentration of 1 106 cells/well were
restimulated in vitro for 24 h in the presence of 3 g/ml tgD,
1 g/ml gD, 3 g/ml tgB, or 1 g/ml gB, and the culture
supernatants were collected and stored at 20°C. Polysty-
rene microtiter plates (Immulon II, Dynatech Laboratories)
were coated with 2 g/ml of antimurine IL-5 or IFN- IgG
(Pharmingen, San Diego, CA, USA) overnight at 4°C.
Plates were washed and blocked with 1% BSA/PBS for 1 h
at RT. After decanting, antigen-stimulated or untreated cell
culture supernatants were added and plates were incubated
for 2 h at RT. After washing, biotinylated antimurine IL-5
or IFN- IgG (Pharmingen) diluted to 3 g/ml in 1%
BSA/PBS was added to the appropriate wells. After 2 h
incubation at RT, plates were washed in PBST, and strepta-
vidin–alkaline phosphatase (Canadian Life Technologies) in
1% BSA/PBS was added at a dilution of 1:2500. After 1 h
incubation at RT, plates were washed and reactions were
visualized with 0.01 M PNPP (Sigma-Aldrich). Absor-
bances were read on a model 3550 Microplate Reader (Bio-
Rad Laboratories) at 405 nm with a reference wavelength of
490 nm. The amounts of antigen-specific IFN- were cal-
culated using doubling dilutions of IFN-, which were
present on all plates with a range of 10 ng/ml to 5 pg/ml.
Statistical analyses
All data were analyzed with the aid of a statistical soft-
ware program (GraphPad Prism version 3.0 for Windows,
GraphPad Software, San Diego, CA). Prior to performance
of analyses, antibody titers and IFN- levels were trans-
formed by log transformation to obtain normally distributed
data. One-way analysis of variance with Bonferroni’s post-
test was used to measure the differences between selected
groups.
Acknowledgments
We thank Brenda Karvonen, Laura Latimer, Tamela
King, Reno Pontarollo, and Valeria Alcon for expert tech-
nical assistance. We also thank Barry Carroll, Tracy Bru-
neau, Carolyn Olson, Jamie Mamer, Sherri Tetland, and Jan
Erickson for care and handling of the animals. L.A.B. is
holder of a Canada research chair in vaccinology. This work
was funded by Natural Science and Engineering Research
Council, Canadian Institutes of Health Research, Alberta
Agricultural Research Institute, and Agricultural Develop-
ment Fund of Saskatchewan.
References
Braun, R., Babiuk, L.A., van Drunen Littel-van den Hurk, S., 1997.
Enhanced immune response to an intradermally delivered DNA vac-
cine expressing a secreted form of BHV-1 gD. Vaccine Res. 6, 151–
164.
Braun, R., Babiuk, L.A., van Drunen Littel-van den Hurk, H., 1998.
Compatibility of plasmids expressing different antigens in a single
DNA vaccine formulation. J. Gen. Virol. 79, 2965–2970.
Campadelli-Fiume, G., Cocchi, F., Menotti, L., Lopez, M., 2000. The novel
receptors that mediate the entry of herpes simplex viruses and animal
alphaherpesviruses into cells. Rev. Med. Virol. 10, 305–319.
Chase, C.C., Lohff, C., Letchworth 3rd, G.J., 1993. Resistance and sus-
ceptibility of bovine cells expressing herpesviral glycoprotein D ho-
mologs to herpesviral infections. Virology 194, 365–369.
Chen, H., Kim, J., Kendall, D.A., 1996. Competition between functional
signal peptides demonstrates variation in affinity for the secretion
pathway. J. Bacteriol. 178, 6658–6664.
Cotten, M., Baker, A., Saltik, M., Wagner, E., Buschle, M., 1994. Lipo-
polysaccharide is a frequent contaminant of plasmid DNA preparations
and can be toxic to primary human cells in the presence of adenovirus.
Gene Ther. 1, 239–246.
Deck, R.R., DeWitt, C.M., Donnelly, J.J., Liu, M.A., Ulmer, J.B., 1997.
Characterization of humoral immune responses induced by an influenza
hemagglutinin DNA vaccine. Vaccine 15, 71–78.
306 S. Manoj et al. / Virology 313 (2003) 296–307
Donnelly, J.J., Ulmer, J.B., Shiver, J.W., Liu, M.A., 1997. DNA vaccines.
Annu. Rev. Immunol. 15, 617–648.
Fitzpatrick, D.R., Redmond, M.J., Attah-Poku, S.K., van Drunen Littel-van
den Hurk, S., Babiuk, L.A., Zamb, T.J., 1990. Mapping of 10 epitopes
on bovine herpesvirus type 1 glycoproteins gI and gIII. Virology 176,
145–157.
Galliciotti, G., Schneider, H., Wyder, L., Vitaliti, A., Wittmer, M., Ajmo,
M., Klemenz, R., 2001. Signal-sequence trap in mammalian and yeast
cells: a comparison. J. Membr. Biol. 183, 175–182.
Gao, Y., Leary, T.P., Eskra, L., Splitter, G.A., 1994. Truncated bovine
herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune
response in its natural host. Vaccine 12, 145–152.
Gao, Y., Wang, C., Splitter, G.A., 1999. Mapping T and B lymphocyte
epitopes of bovine herpesvirus-1 glycoprotein B. J. Gen. Virol. 80,
2699–2704.
Ghattas, I.R., Sanes, J.R., Majors, J.E., 1991. The encephalomyocarditis
virus internal ribosome entry site allows efficient coexpression of two
genes from a recombinant provirus in cultured cells and in embryos.
Mol. Cell. Biol. 11, 5848–5859.
Grifantini, R., Finco, O., Bartolini, E., Draghi, M., Del Giudice, G.,
Kocken, C., Thomas, A., Abrignani, S., Grandi, G., 1998. Multi-
plasmid DNA vaccination avoids antigenic competition and enhances
immunogenicity of a poorly immunogenic plasmid. Eur. J. Immunol.
28, 1225–1232.
Guan, J., Ma, L., Wei, L., 2001. Characteristics of ovarian cancer cells
transduced by the bicistronic retroviral vector containing GM-CSF and
HSV-TK genes. Chin. Med. J. (Engl.) 114, 147–151.
Hughes, G., Babiuk, L.A., van Drunen Littel-van den Hurk, S., 1988.
Functional and topographical analyses of epitopes on bovine herpes-
virus type 1 glycoprotein IV. Arch. Virol. 103, 47–60.
Kedl, R.M., Rees, W.A., Hildeman, D.A., Schaefer, B., Mitchell, T.,
Kappler, J., Marrack, P., 2000. T cells compete for access to antigen-
bearing antigen-presenting cells. J. Exp. Med. 192, 1105–1113.
Kirchhoff, S., Koster, M., Wirth, M., Schaper, F., Gossen, M., Bujard, H.,
Hauser, H., 1995. Identification of mammalian cell clones exhibiting
highly regulated expression from inducible promoters. Trends Genet.
11, 219–220.
Kumamoto, C.A., 1991. Molecular chaperones and protein translocation
across the Escherichia coli inner membrane. Mol. Microbiol. 5, 19–22.
Kumamoto, C.A., Beckwith, J., 1985. Evidence for specificity at an early
step in protein export in Escherichia coli. J. Bacteriol. 163, 267–274.
Kwissa, M., Unsinger, J., Schirmbeck, R., Hauser, H., Reimann, J., 2000.
Polyvalent DNA vaccines with bidirectional promoters. J. Mol. Med.
78, 495–506.
Kyte, J., Doolittle, R.F., 1982. A simple method for displaying the hydro-
pathic character of a protein. J. Mol. Biol. 157, 105–132.
Lewis, P.J., van Drunen Littel-van den Hurk, S., Babiuk, L.A., 1999.
Development of immune responses in the presence of passive antibody.
J. Gen. Virol. 80, 2829–2837.
Li, Y., Liang, X., van Drunen Littel-van den Hurk, S., Attah-Poku, S.,
Babiuk, L.A., 1996a. Glycoprotein Bb, the N-terminal subunit of bo-
vine herpesvirus 1 gB, can bind to heparan sulfate on the surfaces of
Madin-Darby bovine kidney cells. J. Virol. 70, 2032–2037.
Li, Y., van Drunen Littel-van den Hurk, S., Liang, X., Babiuk, L.A., 1996b.
Production and characterization of bovine herpesvirus 1 glycoprotein B
ectodomain derivatives in an hsp70A gene promoter-based expression
system. Arch. Virol. 141, 2019–2029.
Liacopoulos, P., Ben-Efraim, S., 1975. Antigenic competition. Prog. Al-
lergy 18, 97–204.
Loehr, B.I., Pontarollo, R., Rankin, R., Latimer, L., Willson, P., Babiuk,
L.A., van Drunen Littel-van den Hurk, S., 2001. Priming by DNA
immunization augments T-cell responses induced by modified live
bovine herpesvirus vaccine. J. Gen. Virol. 82, 3035–3043.
Mizuguchi, H., Xu, Z., Ishii-Watabe, A., Uchida, E., Hayakawa, T., 2000.
IRES-dependent second gene expression is significantly lower than
cap-dependent first gene expression in a bicistronic vector. Mol. Ther.
1, 376–382.
Musacchio, A., Rodriguez, E.G., Herrera, A.M., Quintana, D., Muzio, V.,
2001. Multivalent DNA-based immunization against hepatitis B virus
with plasmids encoding surface and core antigens. Biochem. Biophys.
Res. Commun. 282, 442–446.
O’Hagan, D., Singh, M., Ugozzoli, M., Wild, C., Barnett, S., Chen, M.,
Schaefer, M., Doe, B., Otten, G.R., Ulmer, J.B., 2001. Induction of
potent immune responses by cationic microparticles with adsorbed
human immunodeficiency virus DNA vaccines. J. Virol. 75, 9037–
9043.
Pancholi, P., Liu, Q., Tricoche, N., Zhang, P., Perkus, M.E., Prince, A.M.,
2000. DNA prime-canarypox boost with polycistronic hepatitis C virus
(HCV) genes generates potent immune responses to HCV structural
and nonstructural proteins. J. Infect. Dis. 182, 18–27.
Rhodes, G.H., Abai, A.M., Margalith, M., Kuwahara-Rundell, A., Morrow,
J., Parker, S.E., Dwarki, V.J., 1994. Characterization of humoral im-
munity after DNA injection. Dev. Biol. Stand. 82, 229–236.
Ros, C., Belak, S., 2002. Characterization of the glycoprotein B gene from
ruminant alphaherpesviruses. Virus Genes 24, 99–105.
Rusch, S.L., Chen, H., Izard, J.W., Kendall, D.A., 1994. Signal peptide
hydrophobicity is finely tailored for function. J. Cell. Biochem. 55,
209–217.
Schneider, S.C., Sercarz, E.E., 1997. Antigen processing differences
among APC. Hum. Immunol. 54, 148–158.
Sharma, S., Wang, J., Huang, M., Paul, R.W., Lee, P., McBride, W.H.,
Economou, J.S., Roth, M.D., Kiertscher, S.M., Dubinett, S.M., 1996.
Interleukin-7 gene transfer in non-small-cell lung cancer decreases
tumor proliferation, modifies cell surface molecule expression, and
enhances antitumor reactivity. Cancer Gene Ther. 3, 302–313.
Staal, F.J., Bakker, A.Q., Verkuijlen, M., van Oort, E., Spits, H., 1996. Use
of bicistronic retroviral vectors encoding the LacZ gene together with
a gene of interest: a method to select producer cells and follow trans-
duced target cells. Cancer Gene Ther. 3, 345–351.
Tikoo, S.K., Campos, M., Babiuk, L.A., 1995. Bovine herpesvirus 1
(BHV-1): biology, pathogenesis, and control. Adv. Virus Res. 45,
191–223.
van Drunen Littel-van den Hurk, S., Braun, R.P., Lewis, P.J., Karvonen,
B.C., Baca-Estrada, M.E., Snider, M., McCartney, D., Watts, T.,
Babiuk, L.A., 1998. Intradermal immunization with a bovine herpes-
virus-1 DNA vaccine induces protective immunity in cattle. J. Gen.
Virol. 79, 831–839.
van Drunen Littel-van den Hurk, S., Gerdts, V., Loehr, B.I., Pontarollo, R.,
Rankin, R., Uwiera, R., Babiuk, L.A., 2000. Recent advances in the use
of DNA vaccines for the treatment of diseases of farmed animals. Adv.
Drug Deliv. Rev. 43, 13–28.
van Drunen Littel-van den Hurk, S., Parker, M.D., Massie, B., van den
Hurk, J.V., Harland, R., Babiuk, L.A., Zamb, T.J., 1993. Protection of
cattle from BHV-1 infection by immunization with recombinant gly-
coprotein gIV. Vaccine 11, 25–35.
van Drunen Littel-van den Hurk, S., van den Hurk, J.V., Babiuk, L.A.,
1985. Topographical analysis of bovine herpesvirus type-1 glycopro-
teins: use of monoclonal antibodies to identify and characterize func-
tional epitopes. Virology 144, 216–227.
van Drunen Littel-van den Hurk, S., van den Hurk, J.V., Gilchrist, J.E.,
Misra, V., Babiuk, L.A., 1984. Interactions of monoclonal antibodies
and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization
of their biochemical and immunological properties. Virology 135,
466–479.
Wang, C., Sarnow, P., Siddiqui, A., 1993. Translation of human hepatitis
C virus RNA in cultured cells is mediated by an internal ribosome-
binding mechanism. J. Virol. 67, 3338–3344.
Wild, J., Gruner, B., Metzger, K., Kuhrober, A., Pudollek, H.P., Hauser,
H., Schirmbeck, R., Reimann, J., 1998. Polyvalent vaccination against
hepatitis B surface and core antigen using a dicistronic expression
plasmid. Vaccine 16, 353–360.
307S. Manoj et al. / Virology 313 (2003) 296–307
